Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adavosertib in CCNE1-amplified solid tumors
NCT03253679Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adavosertib in solid tumor, sponsored by National Cancer Institute. Started Jan 2019; status: completed.
02
Drugs
adavosertib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03253679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03253679.